Evidence map›Paper›PMID 37269530›Full record

ArticlePediatric blood & cancer2023

Clinic reported facilitators and barriers to pediatric cancer survivor care delivery among survivorship clinics: A fishbone analysis.

Victoria Krauss, Ann Mertens, Jordan Gilleland Marchak, Regine Haardörfer, Lillian R Meacham, Rebecca Williamson Lewis, Robert Wright, Oyinda Adisa, Apoorva Kommajosula, Cam Escoffery

Abstract read
In one paragraph

Article in Pediatric blood & cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Victoria KraussRollins School of Public Health, Emory University, Atlanta, Georgia, USA.ORCID 0009-0002-7191-6967
Ann MertensAflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, Georgia, USA.ORCID 0000-0003-0989-0962
Jordan Gilleland MarchakAflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Regine HaardörferRollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Lillian R MeachamAflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Rebecca Williamson LewisAflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, Georgia, USA.ORCID 0000-0003-1722-0547
Robert WrightRollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Oyinda AdisaRollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Apoorva KommajosulaRollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Cam EscofferyRollins School of Public Health, Emory University, Atlanta, Georgia, USA.

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
Health Promotion and Disease Prevention Research CenterU48DP006377 · DP · EMORY UNIVERSITY · PI KEGLER, MICHELLE C · 2018 to 2023
$13.5M
SurvivorLink: Scalability of an Electronic Personal Health Record for Cancer Survivors and Caregivers at Pediatric Cancer Centers.R01CA218389 · NCI · EMORY UNIVERSITY · PI ESCOFFERY, NGOC-CAM, MERTENS, ANN C · 2018 to 2022
$3.1M
CDC HHS U48 DP006377NCCDPHP CDC HHS U48 DP006377NCI NIH HHS P30 CA138292NCI NIH HHS R01 CA218389NCI NIH HHS R01CA218389
6 · The paper itself

Abstract

backgroundChildhood cancer survivors need regular, long-term survivor care. The Children's Oncology Group (COG) recommends that pediatric patients receive ongoing, evidence-based surveillance for late effects, beginning 2 years after the completion of cancer therapy. However, at least a third of survivors are not engaging in long-term survivorship care. This study assessed facilitators and barriers to follow-up survivorship care through the perspectives of pediatric cancer survivor clinic representatives.

methodsAs part of a hybrid implementation-effectiveness trial, a representative from 12 participating pediatric cancer survivor clinics completed a survey about site characteristics and a semi-structured interview on facilitators and barriers to survivor care delivery at their institution. Interviews were grounded in the socio-ecological model (SEM) framework and utilized a fishbone diagram to understand what facilitates and impedes survivor care. We ran descriptive statistics and conducted thematic analyses of the interview transcripts to create two meta-fishbone diagrams.

resultsAll participating clinics (N = 12) have existed for at least 5 years (mean = 15, median = 13, range = 3-31), and half (n = 6, 50%) reported seeing more than 300 survivors annually. In the fishbone diagram, the top facilitators were in the SEM domain of organization, specifically with familiar staff (n = 12, 100%), resource utilization (n = 11, 92%), dedicated survivorship staff (n = 10, 83%), and clinic processes (n = 10, 83%). Common barriers were across the domains of organization, community, and policy, which included distance/transportation to the clinic (n = 12, 100%), technology limits (n = 11, 92%), scheduling issues (n = 11, 92%), and insufficient funding/insurance (n = 11, 92%).

conclusionClinic staff and provider perceptions are instrumental in understanding multilevel contextual issues related to survivor care delivery for pediatric cancer survivor clinics. Future research can aid in developing education, processes, and services to promote cancer survivor follow-up care.

Indexed as

Cancer SurvivorsNeoplasmsChildDelivery of Health CareHumansSurvivorsSurvivorshipcare deliveryclinic levelfishbonepediatric cancerSEMsurvivorship

Identifiers

PMID37269530
PMCPMC10332386

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.